Profile
Richard A. Silva is Senior Vice President-Technical Operations at LB Pharmaceuticals, Inc. since 2025.
Formerly, Dr. Silva was Senior Vice President-Pharmaceutical Sciences at Carmot Therapeutics, Inc. from 2023 to 2024, VP-Technical Operations & Development at Epizyme, Inc. from 2020 to 2023, Senior Director at Kaleido Biosciences, Inc. from 2019 to 2020, and Senior Director-Chemical Process Development at ImmunoGen, Inc. from 2015 to 2019.
Education includes a doctorate from Dartmouth College and an undergraduate degree from the University of Massachusetts.
Richard Silva active positions
| Companies | Position | Start |
|---|---|---|
| LB PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01/02/2025 |
Former positions of Richard Silva
| Companies | Position | End |
|---|---|---|
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Corporate Officer/Principal | 01/07/2024 |
| EPIZYME, INC. | Corporate Officer/Principal | 01/04/2023 |
| KALEIDO BIOSCIENCES, INC. | Director/Board Member | 01/02/2020 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01/03/2019 |
Training of Richard Silva
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops drugs for inflammatory, metabolic and neurological diseases | Health Technology |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
- Stock Market
- Insiders
- Richard Silva
















